Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Dnajc22 Inhibitors

Dnajc22 Inhibitors constitute a distinctive class of chemical compounds that hold the capacity to modulate the activity of the DNJC22 protein, a member of the DnaJ/Hsp40 family. This class of proteins is recognized for its pivotal role in a multitude of cellular processes, primarily centered around protein folding, chaperone-assisted protein quality control, and intracellular trafficking. The DNJC22 protein, in particular, operates as an essential co-chaperone, facilitating the proper folding of client proteins and assisting in their productive integration into cellular pathways. Inhibitors tailored to target DNJC22 exhibit a specific mode of action, which usually involves the binding to discrete binding sites or functional domains within the protein's structure. By engaging with these specific regions, these inhibitors can effectively influence the conformational dynamics of the protein or hamper its interactions with other cellular components. Through these actions, the inhibitors have the potential to disrupt the intricate network of processes DNJC22 participates in.

As researchers delve into the exploration of DNJC22 inhibitors, the primary objective revolves around deciphering the precise implications of manipulating the protein's activity. By utilizing these inhibitors as molecular tools, scientists can illuminate the protein's functional relevance across diverse cellular pathways. Furthermore, this approach might yield insights into the underlying mechanisms of protein folding and quality control, shedding light on broader cellular processes. Instead, the focus rests on deciphering the intricate cellular ballet orchestrated by DNJC22 and its implications for cellular homeostasis. This fundamental research holds the potential to unravel new facets of cellular biology, thereby contributing to a deeper understanding of the complexity that underlies cellular function. As scientific understanding evolves, the pursuit of DNJC22 inhibitors continues to shape the landscape of molecular and cellular research.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Binds to the ATP-binding site of specific tyrosine kinases, inhibiting their activity and interrupting cell signaling pathways.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Blocks the proteasome, leading to accumulation of proteins and triggering cell death pathways.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Inhibits histone deacetylases, leading to altered gene expression and potential anti-cancer effects.

Atorvastatin

134523-00-5sc-337542A
sc-337542
50 mg
100 mg
$257.00
$505.00
9
(1)

Blocks HMG-CoA reductase, lowering blood cholesterol levels.

Ritonavir

155213-67-5sc-208310
10 mg
$124.00
7
(1)

Inhibits the HIV protease enzyme, preventing viral replication.

Donepezil

120014-06-4sc-279006
10 mg
$74.00
3
(1)

Blocks acetylcholinesterase, improving cognitive function in Alzheimer's disease.

Acetazolamide

59-66-5sc-214461
sc-214461A
sc-214461B
sc-214461C
sc-214461D
sc-214461E
sc-214461F
10 g
25 g
100 g
250 g
500 g
1 kg
2 kg
$81.00
$177.00
$434.00
$541.00
$883.00
$1479.00
$2244.00
1
(1)

Inhibits carbonic anhydrase enzyme, used for glaucoma and altitude sickness.

Anastrozole

120511-73-1sc-217647
10 mg
$92.00
1
(1)

Inhibits aromatase enzyme, used in for hormone receptor-positive breast cancer.

Oseltamivir

196618-13-0sc-507283
100 g
$324.00
(0)

Inhibits influenza neuraminidase enzyme, preventing viral particle release.

3′-Azido-3′-deoxythymidine

30516-87-1sc-203319
10 mg
$61.00
2
(1)

Inhibits HIV reverse transcriptase, used in antiretroviral therap